Matrix Capital Management Company, LP 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-19 4:35 pm Unchanged | 2025-05-16 | 13D | Aura Biosciences, Inc. AURA | Matrix Capital Management Company, LP | 6,922,870 11.170% | 0 (Unchanged) | Filing |
| 2023-11-09 4:34 pm Purchase | 2023-11-09 | 13D | Aura Biosciences, Inc. AURA | Matrix Capital Management Company, LP | 6,922,870 14.100% | 1,560,000 (+29.09%) | Filing |
| 2022-12-07 4:30 pm Purchase | 2022-12-05 | 13D | Aura Biosciences, Inc. AURA | Matrix Capital Management Company, LP | 5,362,870 14.500% | 1,250,000 (+30.39%) | Filing |
| 2021-11-04 4:58 pm Purchase | 2021-11-02 | 13D | Aura Biosciences, Inc. AURA | Matrix Capital Management Company, LP | 4,112,870 14.480% | 4,112,870 (New Position) | Filing |